Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Fidia Spa ( (IT:FDA) ) has shared an announcement.
Fidia S.p.A. announced the conversion of five bonds into 277,777 new shares at a price of Euro 0.18 per share, as part of a convertible bond loan with GGHL. This conversion increases the company’s share capital by Euro 50,000, bringing the total to Euro 7,847,761.90, and the total number of shares to 15,227,312. This move reflects Fidia’s ongoing financial strategies and its commitment to maintaining a strong market presence.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.50 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., based in San Mauro Torinese, is a global leader in the design, production, and marketing of high-performance integrated milling systems. The company primarily serves the automotive and aerospace sectors, offering comprehensive solutions for the entire milling process. With over 50 years of experience and approximately 135 employees, Fidia specializes in numerical controls, high-speed milling systems, and CAM software for complex shapes.
Average Trading Volume: 482,036
Technical Sentiment Signal: Strong Sell
Current Market Cap: €2M
Learn more about FDA stock on TipRanks’ Stock Analysis page.